ACUVAIL®

Drug Information Related Patent

Hold Company

ABBVIE

Dosage and Administration

SOLUTION/DROPS;OPHTHALMIC

Specification

0.45%

Indication

ACUVAIL® is indicated for the treatment of pain and inflammation after cataract surgery.

Use

Instructions for Use

API

KETOROLAC TROMETHAMINE

API Structure

We Supply

Note:

USP
Facility GMP
Product GMP
USMF/CEP

Note:

null

Note:

null

Drug Patent

API Patent

Patent No	Expiration Date
7842714	2029/8/15

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION

Member of